https://www.marketscreener.com/quote/stock/EDGEWISE-THERAPEUTICS-INC-120591108/news/Edgewise-Receives-European-Medicines-Agency-Orphan-Drug-Designations-for-Sevasemten-for-the-Treatmen-46516434/?utm_source=telegram&utm_medium=social&utm_campaign=share